Evidence map›Paper›PMID 18562623›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2008

Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system.

Arati Kreibich, Beverly A S Reyes, Andre L Curtis, Laurel Ecke, Charles Chavkin, Elisabeth J Van Bockstaele, Rita J Valentino

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 104 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Peripheral CD4Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Opioid Mechanisms and the Treatment of Depression.Current topics in behavioral neurosciences · 2024
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Untangling the complexity of opioid receptor function.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Arati KreibichThe Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA. aratik@mail.med.upenn.edu
Beverly A S Reyes
Andre L Curtis
Laurel Ecke
Charles Chavkin
Elisabeth J Van Bockstaele
Rita J Valentino
Children's Hospital of Philadelphia · USThomas Jefferson University · USUniversity of Pennsylvania · USUniversity of Washington · US

Funding

Training Program in Neurodevelopmental DisabilitiesT32NS007413 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI AMELIA J EISCH, ERIC D MARSH · 1998 to 2026
$8.9M
OPIOID MODULATION OF THE COERULEO-CORTICAL PATHWAYR01DA009082 · NIDA · THOMAS JEFFERSON UNIVERSITY · PI VAN BOCKSTAELE, ELISABETH J · 2001 to 2017
$6.0M
Opioid mediation of stress-potentiated cocaine responseR01DA016898 · NIDA · UNIVERSITY OF WASHINGTON · PI CHAVKIN, CHARLES · 2003 to 2007
$1.3M
OPIOID MODULATION OF THE COERULEO-CORTICAL PATHWAYR29DA009082 · NIDA · WEILL MEDICAL COLLEGE OF CORNELL UNIV · PI VAN BOCKSTAELE, ELISABETH J · 1994 to 1998
–
NIDA NIH HHS DA09082NIDA NIH HHS DA16898NIDA NIH HHS R01 DA009082NIDA NIH HHS R01 DA016898NINDS NIH HHS T32 NS007413NINDS NIH HHS T32NS007413
6 · The paper itself

Abstract

The norepinephrine nucleus, locus ceruleus (LC), is activated by diverse stimuli and modulates arousal and behavioral strategies in response to these stimuli through its divergent efferent system. Afferents communicating information to the LC include excitatory amino acids (EAAs), corticotropin-releasing factor (CRF), and endogenous opioids acting at mu-opiate receptors. Because the LC is also innervated by the endogenous kappa-opiate receptor (kappa-OR) ligand dynorphin and expresses kappa-ORs, this study investigated kappa-OR regulation of LC neuronal activity in rat. Immunoelectron microscopy revealed a prominent localization of kappa-ORs in axon terminals in the LC that also contained either the vesicular glutamate transporter or CRF. Microinfusion of the kappa-OR agonist (trans)-3,4-dichloro-N-methyl-N-[2-1-pyrrolidinyl)-cyclo-hexyl] benzeneacetamide (U50488) into the LC did not alter LC spontaneous discharge but attenuated phasic discharge evoked by stimuli that engage EAA afferents to the LC, including sciatic nerve stimulation and auditory stimuli and the tonic activation associated with opiate withdrawal. Inhibitory effects of the kappa-OR agonist were not restricted to EAA afferents, as U50488 also attenuated tonic LC activation by hypotensive stress, an effect mediated by CRF afferents. Together, these results indicate that kappa-ORs are poised to presynaptically inhibit diverse afferent signaling to the LC. This is a novel and potentially powerful means of regulating the LC-norepinephrine system that can impact on forebrain processing of stimuli and the organization of behavioral strategies in response to environmental stimuli. The results implicate kappa-ORs as a novel target for alleviating symptoms of opiate withdrawal, stress-related disorders, or disorders characterized by abnormal sensory responses, such as autism.

Indexed as

3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-IsomerAnimalsLocus CoeruleusNeural InhibitionNeural PathwaysNeurons, AfferentNorepinephrinePresynaptic TerminalsRatsRats, Sprague-DawleyReceptors, Opioid, kappa3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-IsomerNorepinephrineReceptors, Opioid, kappa

Identifiers

PMID18562623
PMCPMC2605626
OpenAlexW1971030284

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.